Cite
APA Citation
Sweet, K., Dasgupta, B., de Vries, D., Gourley, I., Hsu, B., Loza, M. J., & Taylor, P. C. (2019). sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial. Annals of the rheumatic diseases, 78(10), 1439–1441. http://access.bl.uk/ark:/81055/vdc_100175517232.0x00005a